Author:
Krabbe Laura-Maria,Woldu Solomon L.,Sanli Oner,Margulis Vitaly
Publisher
Springer International Publishing
Reference164 articles.
1. Abel EJ, Culp SH, et al. Early primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib. Eur Urol. 2011;60(6):1273–9.
2. Abern MR, Scosyrev E, et al. Survival of patients undergoing cytoreductive surgery for metastatic renal cell carcinoma in the targeted-therapy era. Anticancer Res. 2014;34(5):2405–11.
3. Aizer AA, Urun Y, et al. Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC). BJU Int. 2014;113(5b):E67–74.
4. Alt AL, Boorjian SA, et al. Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer. 2011;117(13):2873–82.
5. Altoos B, Amini A, et al. Local control rates of metastatic renal cell carcinoma (RCC) to thoracic, abdominal, and soft tissue lesions using stereotactic body radiotherapy (SBRT). Radiat Oncol. 2015;10:218.